Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q32 Bio Inc. Director's Dealing 2024

Oct 10, 2024

34891_dirs_2024-10-10_24972a85-055f-450b-b480-12003ccfad65.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-10-08

Reporting Person: Violette Shelia M. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-08 Common Stock M 13300 $3.12 Acquired 13300 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-10-08 Stock Option (Right to Buy) $3.12 M 13300 Disposed 2028-12-06 Common Stock (13300) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 36277 Indirect

Footnotes

F1: Shares held by Violette Holdings LLC ("Violette Holdings"). The Reporting Person is a manager of Violette Holdings and disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose.

F2: The shares underlying this option are fully vested and exercisable as of the date hereof.